116 related articles for article (PubMed ID: 2128051)
1. Prolactin secretion in myotonic dystrophy.
Marinković Z; Prelevic G; Han R; Würzburger M; Todorovic S
Exp Clin Endocrinol; 1990 Dec; 96(3):247-52. PubMed ID: 2128051
[TBL] [Abstract][Full Text] [Related]
2. Dynamic evaluation of prolactin secretion by successive TRH and metoclopramide stimulations.
Kauppila A; Heikkinen J; Viinikka L
Acta Endocrinol (Copenh); 1986 Jan; 111(1):10-6. PubMed ID: 3080846
[TBL] [Abstract][Full Text] [Related]
3. The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly.
Lamberts SW; Liuzzi A; Chiodini PG; Verde S; Klijn JG; Birkenhäger JC
Eur J Clin Invest; 1982 Apr; 12(2):151-5. PubMed ID: 6807686
[TBL] [Abstract][Full Text] [Related]
4. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
Spitz IM; Haas M; Trestian S; Zylber-Haran E; Shilo S
Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745
[TBL] [Abstract][Full Text] [Related]
5. Prolactin-secreting pituitary adenomas: prolactin dynamics before and after transsphenoidal surgery.
Barbarino A; de Marinis L; Menini E; Anile C; Maira G
Acta Endocrinol (Copenh); 1979 Jul; 91(3):397-409. PubMed ID: 112818
[TBL] [Abstract][Full Text] [Related]
6. [Value of the metoclopramide test in diagnosis of hormonal causes of female sterility].
Matt O; Gerhard I; Runnebaum B
Zentralbl Gynakol; 1992; 114(11):539-46. PubMed ID: 1481585
[TBL] [Abstract][Full Text] [Related]
7. Effect of bromocriptine and metoclopramide on serum prolactin levels in patients with amyotrophic lateral sclerosis.
Szulc-Kuberska J; Stepień H; Klimek A; Cieślak D
J Neurol Neurosurg Psychiatry; 1988 May; 51(5):643-5. PubMed ID: 3404163
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic value of pharmacodynamic tests in the hyperprolactinaemic syndrome.
Ayalon D; Persitz E; Ravid R; Jedwab G; Avidan S; Cordova T; Harell A
Clin Endocrinol (Oxf); 1979; 11(2):201-15. PubMed ID: 114343
[TBL] [Abstract][Full Text] [Related]
9. Effects of a dopamine antagonist (metoclopramide) on the release of the adenohypophyseal hormones in amenorrhoeic patients with and without hyperprolactinaemia.
Seki K; Uesato T; Kato K
Acta Endocrinol (Copenh); 1982 Oct; 101(2):166-70. PubMed ID: 6814135
[TBL] [Abstract][Full Text] [Related]
10. Bromocriptine suppression of TRH-stimulated prolactin and thyrotrophin release and accompanying inhibition of bromocriptine induced growth hormone release by TRH in normal man.
Brown PM; Bacchus R; Sachs L; Sönksen PH; Wheeler M
Clin Endocrinol (Oxf); 1979 May; 10(5):481-8. PubMed ID: 113143
[TBL] [Abstract][Full Text] [Related]
11. Prolactin response to metoclopramide and thyrotropin-releasing hormone in normoprolactinemic and hyperprolactinemic women: a comparison of diagnostic validity.
Bussen S; Brosemann N; Steck T
Gynecol Endocrinol; 1996 Apr; 10(2):83-90. PubMed ID: 8701791
[TBL] [Abstract][Full Text] [Related]
12. Lack of dissociation of prolactin responses to thyrotropin releasing hormone and metoclopramide in chronic alcoholic men.
Van Thiel DH; Gavaler JS; Sanghvi A
J Endocrinol Invest; 1982; 5(5):281-6. PubMed ID: 6818270
[TBL] [Abstract][Full Text] [Related]
13. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
Hirvonen E; Ranta T; Seppäla M
J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
[TBL] [Abstract][Full Text] [Related]
14. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery.
Scanlon MF; Peters JR; Salvador J; Richards SH; John R; Howell S; Williams ED; Thomas JP; Hall R
Clin Endocrinol (Oxf); 1986 Apr; 24(4):435-46. PubMed ID: 3091297
[TBL] [Abstract][Full Text] [Related]
15. Tests of prolactin secretion in diagnosis of prolactinomas.
Cowden EA; Ratcliffe JG; Thomson JA; Macpherson P; Doyle D; Teasdale GM
Lancet; 1979 Jun; 1(8127):1155-8. PubMed ID: 86882
[TBL] [Abstract][Full Text] [Related]
16. Hyperthyroidism due to inappropriate TSH secretion with associated hyperprolactinaemia--a case report and review of the literature.
Spitz IM; Sheinfeld M; Glasser B; Hirsch HJ
Postgrad Med J; 1984 May; 60(703):328-35. PubMed ID: 6429655
[TBL] [Abstract][Full Text] [Related]
17. Long-term bromocriptine therapy may restore the inhibitory control of prolactin release in some patients with pathological hyperprolactinemia.
Ho KY; Smythe GA; Compton PJ; Lazarus L
Aust N Z J Med; 1985 Apr; 15(2):213-9. PubMed ID: 3927887
[TBL] [Abstract][Full Text] [Related]
18. The dynamics of prolactin secretion during the puerperium in women.
Vemer HM; Rolland R
Clin Endocrinol (Oxf); 1981 Aug; 15(2):155-63. PubMed ID: 6796300
[TBL] [Abstract][Full Text] [Related]
19. Effects of physiologic and pharmacologic agents on serum prolactin concentrations in the nonpregnant mare.
Johnson AL; Becker SE
J Anim Sci; 1987 Nov; 65(5):1292-7. PubMed ID: 3121569
[TBL] [Abstract][Full Text] [Related]
20. Reduced dopaminergic inhibition of thyrotrophin release in states of physiological hyperprolactinaemia.
Rodriguez-Arnao MD; Weightman DR; Hall R; Scanlon MF; Camporro JM; Gomez-Pan A
Clin Endocrinol (Oxf); 1982 Jul; 17(1):15-9. PubMed ID: 7116653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
